ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply.

Bartoletti, MicheleAzap, OzlemBarac, AleksandraBussini, LindaErgonul, OnderKrause, RobertMartín-Quirós, AlejandroPaño-Pardo, José RamonPower, NicholasSibani, MarcellaSzabo, BalintTsiodras, SotiriosZollner-Schwetz, InesRodriguez-Baño, JesúsESCMID COVID-19 Treatment Guidelines Panel2023-05-032023-05-032022-01-10http://hdl.handle.net/10668/22125enHumansSARS-CoV-2COVID-19 Drug TreatmentESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply.research article35026374open access10.1016/j.cmi.2021.12.0251469-0691PMC8744251http://www.clinicalmicrobiologyandinfection.com/article/S1198743X21007333/pdfhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744251/pdf